SOCIETY OF INFECTIOUS DISEASES PHAR (EIN 760338459) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1991

Legal Domicile

Principal Officer

SAMUEL AITKENS

Tax Period

2023-01-01 to 2023-12-31

SOCIETY OF INFECTIOUS DISEASES PHAR, founded in 1991, is a small nonprofit that reported $728K in total revenue in fiscal year 2018. Revenue fell 33% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $203K, a strong 28% operating margin.

Mission

SIDP SUPPORTS THE GROWING NUMBER OF PHARMACISTS DEDICATED TO PRACTICING, TEACHING, AND PERFORMING RESEARCH IN THE AREA OF INFECTIOUS DISEASES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $229,500

Program Service Revenue $842,146

Investment Income $129,405

Other Revenue $4,876

TOTAL REVENUE $1,205,927

Expense Breakdown

Grants Paid $95,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $581,665

Other Expenses $540,986

TOTAL EXPENSES $635,986

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,205,927	$890,605	+0.4%
Expenses	$635,986	$640,042	0.0%
Net Income	$569,941	$250,563	+1.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$36,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARGO FARBER	EXECUTIVE DIRECTOR	10.00	Officer	$36,000	$0	$36,000
WHITNEY BUCKEL	MEMBER AT LARGE	1.00	Director	$0	$0	$0
TRACY ZEMBLES	MEMBER AT LARGE	1.00	Director	$0	$0	$0
HELEN NEWLAND	SECRETARY	2.00	Officer Director	$0	$0	$0
KATE DESEAR	TREASURER	2.00	Officer Director	$0	$0	$0
ERIN MCCREARY	PRESIDENT ELECT	2.00	Officer Director	$0	$0	$0
MELISSA JOHNSON	PAST PRESIDENT	2.00	Officer Director	$0	$0	$0
SAMUEL AITKENS	PRESIDENT	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,205,927	$635,986	$4,107,345	$569,941
2022	$890,605	$640,042	$3,389,338	$250,563
2021	$670,027	$318,844	$3,413,255	$351,183
2020	$572,681	$425,523	$3,085,625	$147,158
2019	$784,897	$565,164	$2,563,684	$219,733
2018	$727,865	$525,085	$2,094,358	$202,780

SOCIETY OF INFECTIOUS DISEASES PHAR